Physician profile
Rohit Rangroo
NPI 1225666381
$2,252.92
in general payments reported to CMS, 2019-2025
8 companies · $1,113 in 2025
The $1,113 reported for 2025 was more than what 89% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $450 · 2023: $145 · 2024: $545 · 2025: $1,113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,216 · Food and Beverage: $587.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,216.22 |
| Food and Beverage | $586.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $1,268.72 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $238.68 | 2023-2025 | Ofev |
| Novo Nordisk INC | $217.65 | 2022 | |
| Genzyme Corporation | $179.99 | 2023-2025 | |
| Astrazeneca Pharmaceuticals Lp | $141.02 | 2022-2024 | Tezspire |
| Amgen INC. | $116.10 | 2022 | |
| Merck Sharp & Dohme LLC | $70.48 | 2024-2025 | Winrevair, Keytruda |
| Insmed, INC. | $20.28 | 2023 | Arikayce |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rohit Rangroo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.